Conference Coverage

HIV testing dips during pandemic raise transmission concerns


 

At the local level: Adaptations allowed for continued testing

In a separate report presented at the meeting detailing the experiences at a more local level, Joseph Olsen, MPH, and colleagues with CrescentCare, New Orleans, described a similar reduction of HIV testing in 2020 of 49% in their system, compared with the previous year, down from 7,952 rapid HIV tests in 2019 to 4,034 in 2020.

However, through efforts to continue to provide services during the pandemic, the program was able to link 182 patients to HIV care in 2020, which was up from 172 in 2019.

In addition to offering the rapid HIV testing in conjunction with COVID-19 testing at their urgent care centers, the center adapted to the pandemic’s challenges with strategies including a new at-home testing program; providing testing at a hotel shelter for the homeless; and testing as part of walk-in testing with a syringe access component.

Mr. Olsen credited the swift program adaptations with maintaining testing during the time of crisis.

“Without [those] measures, it would have been a near-zero number of tests provided,” he said in an interview. “It would have been easy to blame the pandemic and not try to find innovations to deliver services, but I credit our incredibly motivated team for wanting to make sure every possible resource was available.”

But now there are signs of possible fallout from the testing reductions that did occur, Mr. Olsen said.

“We are already seeing the increase with other sexually transmitted infections [STIs], and I expect that we will see this with HIV as well,” he said.

In response, clinicians should use diligence in providing HIV testing, Mr. Olsen asserted.

“The take-home message for clinicians is that anyone having sex should get tested for HIV. It’s as easy as that!” he said.

“If they are getting tested for any other STI, make sure an HIV panel is added and discussed. If someone is pregnant, make sure an HIV panel is added and discussed. If someone has never had an HIV test before in their life – and I would add if they haven’t had an HIV test since March of 2020 – make sure an HIV panel is added/discussed,” he said. “Doing this for everyone also reduces stigma around testing. It’s not because any one person or group or risk behavior is being targeted, it is just good public health practice.”

The authors disclosed no relevant financial relationships. Mr. Patel noted that the findings and conclusions of her poster are those of the authors and do not necessarily represent the official position of the CDC.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

HIV prescription mandate controversy reaches the Supreme Court
MDedge Internal Medicine
Maraviroc, metformin fail to control NAFLD in people with HIV
MDedge Internal Medicine
More than half of people living with HIV have coronary plaque
MDedge Internal Medicine
To boost HIV screening, ED nurses need institutional support
MDedge Internal Medicine
Second woman spontaneously clears HIV: ‘We think more are out there’
MDedge Internal Medicine
HIV services are bouncing back from COVID-19 disruptions, data suggest, but recovery is ‘precarious’
MDedge Internal Medicine
HIV: Syringe services fill the gap when clinicians refuse to prescribe PrEP to people who inject drugs
MDedge Internal Medicine
Dr. Fauci: HIV advances ‘breathtaking,’ but steadfast focus on disparities needed
MDedge Internal Medicine
New HIV PrEP guidelines call for clinicians to talk to patients about HIV prevention meds
MDedge Internal Medicine
Inadequate routine diabetes screening common in HIV
MDedge Internal Medicine